Pfizer Stock Falls to 10-Year Low on Guidance Slash. Why Wall Street Is Disappointed.


Pfizer on Wednesday released financial guidance for 2024 that is billions of dollars short of what investors had anticipated, raising questions about the company’s strategy and sending shares lower than they had closed in a decade.

Continue reading this article with a Barron’s subscription.

View Options